Literature DB >> 20156912

The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews.

Jamie J Kirkham1, Kerry M Dwan, Douglas G Altman, Carrol Gamble, Susanna Dodd, Rebecca Smyth, Paula R Williamson.   

Abstract

OBJECTIVE: To examine the prevalence of outcome reporting bias-the selection for publication of a subset of the original recorded outcome variables on the basis of the results-and its impact on Cochrane reviews.
DESIGN: A nine point classification system for missing outcome data in randomised trials was developed and applied to the trials assessed in a large, unselected cohort of Cochrane systematic reviews. Researchers who conducted the trials were contacted and the reason sought for the non-reporting of data. A sensitivity analysis was undertaken to assess the impact of outcome reporting bias on reviews that included a single meta-analysis of the review primary outcome.
RESULTS: More than half (157/283 (55%)) the reviews did not include full data for the review primary outcome of interest from all eligible trials. The median amount of review outcome data missing for any reason was 10%, whereas 50% or more of the potential data were missing in 70 (25%) reviews. It was clear from the publications for 155 (6%) of the 2486 assessable trials that the researchers had measured and analysed the review primary outcome but did not report or only partially reported the results. For reports that did not mention the review primary outcome, our classification regarding the presence of outcome reporting bias was shown to have a sensitivity of 88% (95% CI 65% to 100%) and specificity of 80% (95% CI 69% to 90%) on the basis of responses from 62 trialists. A third of Cochrane reviews (96/283 (34%)) contained at least one trial with high suspicion of outcome reporting bias for the review primary outcome. In a sensitivity analysis undertaken for 81 reviews with a single meta-analysis of the primary outcome of interest, the treatment effect estimate was reduced by 20% or more in 19 (23%). Of the 42 meta-analyses with a statistically significant result only, eight (19%) became non-significant after adjustment for outcome reporting bias and 11 (26%) would have overestimated the treatment effect by 20% or more.
CONCLUSIONS: Outcome reporting bias is an under-recognised problem that affects the conclusions in a substantial proportion of Cochrane reviews. Individuals conducting systematic reviews need to address explicitly the issue of missing outcome data for their review to be considered a reliable source of evidence. Extra care is required during data extraction, reviewers should identify when a trial reports that an outcome was measured but no results were reported or events observed, and contact with trialists should be encouraged.

Mesh:

Year:  2010        PMID: 20156912     DOI: 10.1136/bmj.c365

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  364 in total

1.  Recognizing, investigating and dealing with incomplete and biased reporting of clinical research: from Francis Bacon to the WHO.

Authors:  Kay Dickersin; Iain Chalmers
Journal:  J R Soc Med       Date:  2011-12       Impact factor: 5.344

2.  Selective outcome reporting: telling and detecting true lies. The state of the science.

Authors:  Ana Macura; Iosief Abraha; Jamie Kirkham; Gian Franco Gensini; Lorenzo Moja; Alfonso Iorio
Journal:  Intern Emerg Med       Date:  2010-03-19       Impact factor: 3.397

Review 3.  From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.

Authors:  Kanwal Pratap Singh Raghav; Sminil Mahajan; James C Yao; Brian P Hobbs; Donald A Berry; Rebecca D Pentz; Alda Tam; Waun K Hong; Lee M Ellis; James Abbruzzese; Michael J Overman
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

Review 4.  Treatments for the prevention of Sudden Unexpected Death in Epilepsy (SUDEP).

Authors:  Melissa J Maguire; Cerian F Jackson; Anthony G Marson; Sarah J Nolan
Journal:  Cochrane Database Syst Rev       Date:  2016-07-19

5.  Surgery for epilepsy.

Authors:  Siobhan West; Sarah J Nevitt; Jennifer Cotton; Sacha Gandhi; Jennifer Weston; Ajay Sudan; Roberto Ramirez; Richard Newton
Journal:  Cochrane Database Syst Rev       Date:  2019-06-25

6.  Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Maria Sudell; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-06-24

7.  Multivariate network meta-analysis to mitigate the effects of outcome reporting bias.

Authors:  Hyunsoo Hwang; Stacia M DeSantis
Journal:  Stat Med       Date:  2018-06-07       Impact factor: 2.373

Review 8.  Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

Review 9.  Erythropoiesis-stimulating agents for anemia in rheumatoid arthritis.

Authors:  Arturo J Martí-Carvajal; Luis H Agreda-Pérez; Ivan Solà; Daniel Simancas-Racines
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

Review 10.  Multifocal versus monofocal intraocular lenses after cataract extraction.

Authors:  Samantha R de Silva; Jennifer R Evans; Varo Kirthi; Mohammed Ziaei; Martin Leyland
Journal:  Cochrane Database Syst Rev       Date:  2016-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.